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Summat An increasing incidence of non-Hodgkin's lymphoma (NHL) has been reported in several areas of
the world and often correlated with the occurrence of AIDS-related lymphomas. A registrv specialised in
haematopoietic malignancies enabled us to report detailed time trends in the incidence of NHL over the period
1980-89. There was an overall significant increase in incidence of + 10.9%o per year (P<0.001). Such a trend
was observed both in men and in women (+ 11.2%o and + 10.5%. respectivelv) and in all age groups. It was
slightly more marked in the case of high-grade tumours than for low- or intermediate-grade tumours
(+20.0. + 12.6°o and + 12.6°o respectively) and in rural than in urban areas (+ 19.60o and + 8.1°o
respectively). In this series. onlv one case was associated with an HIV infection. These data indicate that.
although a significant increase in NHL incidence related to the AIDS epidemic might be expected in the near
future. there is an independent dramatic trend which started earlier than the AIDS problem and the causes of
which should be investigated.
NCI's Surveillance. Epidemiology and End Results (SEER)
programme (Miller et al.. 1992) provided evidence that the
incidence of non-Hodgkin's lymphoma (NHL) increased in
the US by nearly 60%. from 8.5 to 13.7 per 100.000, between
1973 and 1989. Devesa and Fears (1992) noted that mortality
and incidence rates have been increasing for many years in
the US and throughout the world.
Such findings suggest a real and worrying phenomenon.
Yet they rely on mean 5 year data. and recent changes in the
classification together with a separate classification of nodal
and extranodal lymphomas may produce some bias. In addi-
tion. the recent AIDS epidemic, with an increasing number
of AIDS-related lymphomas. renders it necessary to deter-
mine precisely the underlying time trend for NHL.
The Registry of Hematopoietic Malignancies (HM) in the
C6te d'Or was established in January 1980. and provides
detailed information on all types of HM diagnosed in sub-
jects residing in the area. Therefore. it is now possible to
study recent trends in incidence for each type of HM. in
particular NHL. The aim of this study was to describe time
trends in NHL incidence over the 10 year period 1980-89 in
the C6te d'Or (France).
Patients and methods
A population-based registry specialising in haematopoietic
malignancies (HMs) was created in the Cote d'Or administ-
rative area (Burgundy. France) in 1980 (Carli et al., 1986).
The C6te d'Or area includes 473,651 inhabitants according to
the 1982 census; it is a stable population with little migration
and 6% foreigners. and it is a relatively young population,
with 13.3% of inhabitants over age 65. Thirty-five per cent of
the population lives in rural areas. Heavy industry represents
only 9% of the economic activity, whereas 60% of workers
are in offices. The registration includes all HMs. in particular
NHL. diagnosed for the first time since 1 January 1980 for
patients residing in the department of C6te d'Or. Inform-
ation is routinely obtained from all pathologists, haematolo-
gists. cancer physicians and medical specialists (gastro-
enterologists, dermatologists, chest disease and infectious
disease physicians) to ensure exhaustivity. The efficiency of
the registry was confirmed by an audit bv the National
Institute for Health and Medical Research (INSERM) in
1989.
All NHLs. both nodal and extranodal. were considered for
this study. Over 10 years. 380 new cases of NHL were
diagnosed in the C6te d'Or in 214 men and 166 women.
Cases were classified according to their histological type in
three groups: low, intermediate and high grade. as defined by
the Working Formulation (National Cancer Institute. 1982).
Age was divided in three groups (<35. 35-64. >64). Place
of residence was defined as urban (towns of more than 2.000
inhabitants) or rural.
For calculating incidence rates. the description of the C6te
d'Or population was obtained from the 1975 and 1982 cen-
sus. by 5 year age groups and by sex. through the French
National Institute for Statistics and Economics (INSEE).
Populations were calculated for each year of the study by
linear interpolation between 1975 and 1982, then by extra-
polation. Incidence rates were then standardised using Segi's
world standard population (Segi & Kurihara. 1969). Time
trends in incidence rates were studied using the hypothesis of
a log linearity of rates with time fitting a least-squares regres-
sion line. The estimated slope and its standard error were
used to calculate a mean percentage of annual variation in
incidence and its confidence interval (CI).
Results
The mean incidence rate over the 10 year period of the study
and the mean percentage of annual variation in incidence are
presented in Table I according to the characteristics of the
NHL. There was an overall 10.9% annual increase in NHL
incidence (P<0.001). This significant increase was observed
both in men and in women (+ 11.2% and + 10.5% respec-
tively) and in all age groups, although it tended to be greater
in the youngest age group than in the other age groups.
The mean incidence rate was lower in rural areas, but the
annual increase was higher in these areas than in urban areas
(+ 19.6%, P<0.01; and + 8.1%, P<0.01. respectively). The
urban to rural incidence ratio was 4.8 in 1980 and decreased
progressively to 1.1 in 1989.
Regarding histological type. 81 cases could not be
classified, but their rate remained steady during the study
period. Of the cases which could be classified, the increase in
incidence was statistically significant in all three groups. but
the greatest increase was observed for high-grade lymphomas
(+ 20.0%, P<0.05). The 3 year smoothed curves of time
trends in incidence for high-. moderate- and low-grade lym-
Correspondence: P.M Carli. Registre des Hemopathies Malignes de
la C6te d'or. Laboratoire d'Hematologie. 2 Bd Marechal de Lattre
de Tassignv. 21034 Dijon Cedex. France.
Receised 23 September 1993; and in resised form 16 February
1994.
Br. J. Cancer (1994). 70, 713-715 (D Macmillan Press Ltd.. 1994714 P.M. CARLI et al.
Table I Time trends in world standardised incidence rates for NHL (per cent annual increase
and 95% confidence intervals
Nu.mwber of Incidence Annual
patients rate' increase (%) (950% CI) P
Global 380 5.8 10.9 (6.7- 15.0) <0.001
Sex
Men 214 7.4 11.2 (6.3- 16.1) <0.01
Women 166 4.2 10.5 (4.7-16.4) <0.01
Age
<35 years 34 1.3 19.1 (1.6-36.6) <0.05
35-64 vears 141 8.6 7.90 (3.2-12.6) <0.01
.65 years 205 33.3 11.4 (3.4-19.4) <0.05
Urban rural
Urban 277 6.9 8.1 (3.0-13.2) <0.01
Rural 103 4.0 19.6 (10.4-28.8) <0.01
Histological grade
Low grade 85 1.4 12.6 (2.0-23.3) <0.05
Intermediate grade 116 1.8 12.6 (5.8-19.4) <0.01
High grade 97 1.5 20.0 (4.9-35.0) <0.05
P. significance of the test for the slope of the log-linear time trend. aMean annual world
standardised incidence rate over the 1980-89 10 year period.
phomas are presented in Figure 1. High-grade lymphomas
were the least common lmphomas up to 1984. but by 1989.
together with intermediate-grade lymphomas, had become
the most common.
Serological testing for HIV from the beginning of the
AIDS epidemic revealed only one case associated with an
HIV infection.
Disusn
The data presented here suggest that there has been a
significant increase in the incidence of NHL over the past 10
years. Such a trend had been discussed in previous studies.
but few were based on a population series. Mortality data
from the 1968-87 period have demonstrated an increase in
mortality rates of NHL in most industrialised countries, in
particular the US. Japan. West Germany, England and
Wales, Italy and France (Davis et al.. 1990). For the
1950-85 penrod. the increase in mortality rates in France was
estimated to be 2.4% in men and 2.7% in women (Hill et al..
1989). Such data are nevertheless subject to bias, including
changes in survival rates, in classification and in quality of
death certification. Incidence data are therefore needed to
ascertain such findings.
When comparing mean incidence rates over 5 year periods
from the last two volumes of Cancer Incidence in Five Con-
tinents (Waterhouse et al., 1982; Muir et al.. 1987), there was
an increase in incidence in several western European coun-
tries, in particular in France in the department of Bas-Rhin,
a region close the C6te d'Or. Japan displayed an important
increase in both sexes, whereas in the US (Connecticut) an
increase was noted in men, in contrast to a decrease in
women. The NCI's Surveillance Epidemiology and End Re-
sults programme studied annual rates and demonstrated an
important increase in incidence over the 1973-89 period
(Miller et al., 1992). In part, it could be explained by im-
provements in diagnosis, as well as by an increasing number
of AIDS-related cases. Yet, even when excluding the latter,
the incidence of NHL has increased in the past two decades
by 3.4% as a mean in patients over 65 years of age.
Our data demonstrate a very sharp increase in NHL in-
cidence in a French region over the past 10 years. Such sharp
increases in the incidence of malignant diseases are rather
uncommon and usually prompt intensive investigation on
aetiological causes. The epidemics of AIDS, in particular in
the US. led to the conclusion that NHL incidence increased
mainly in relation to HIV (Harnly et al.. 1988). A specialised
registry has the advantage of providing detailed information.
Our data clearly demonstrate that the observed sharp in-
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Figre I Times trends in incidence of NHL by grade (C6te
d'Or, France. 1980-89). U. low grade; 0. intermediate grade:
*. high grade.
crease is totally independent of AIDS. although an additional
sharper trend might be expected in the coming years. This
difference with the US situation is the result of the delayed
occurrence of the AIDS epidemic in France, in particular
outside the main cities. Although this sharp increase in
France is a subject of concern, mean incidence rates in the
C6te d'Or are about half those observed for the same period
in the US by the SEER programme.
It is important to discuss possible limitations and biases of
time trends such as those presented here. Our series benefits
from the advantage of close cooperation between three local
pathology centres and their collaboration with national insti-
tutes in following standard diagnostic procedures. In addi-
tion, there is a very good relationship between all physicians
dealing with patients. It is also interesting to note that in the
same region over the same period, no significant change was
observed in any other haematopoietic malignancies, in parti-
cular Hodgkin's disease (Carli et al., 1991).
As for classification, we chose to present cases grouped
according to the Working Formulation. The 1988 Kiel clas-
sification (Standsfeld et al., 1988) uses only two groups. most
intermediate cases being grouped with low-grade cases. This
simpler classification has the disadvantage of being in opposi-
tion with changes in attitudes to therapy, with there being a
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to high-grade NHL (Coiffier & Lepage. 1989). It is interest-
ing to note the trend towards more aggressive lymphomas. A
similar rise in high-grade lymphomas was also observed by
the specialised registry in Leeds. UK (Cartwright et al.,
1990). This is of importance in planning treatment strategies,
as these more aggressive tumours are also the most sensitive
to chemo- and radiotherapy.
Time trends were more significant in rural than in urban
areas. Two hypotheses can be formulated to explain such a
trend. There is some evidence that chemicals which are
increasingly used in farming and that animal viruses which
may infect farmers as well as meat workers are risk factors
for NHL (Pearce et al.. 1987). On the other hand, it should
be emphasised that the incidence of NHL has always been
higher in cities and that the observed increase in NHL in
rural areas might be due to urbanisation of the country with
many rural areas now being inhabited by people working in
towns.
Establishing a baseline trend in the incidence of NHL is of
great importance in order to assess properly potential addi-
tional increases in incidence resulting from the Chernobyl
accident in 1986. So far, no increase in the number of acute
leukaemia cases has been demonstrated by the European
Childhood Leukaemia Lymphoma Incidence Study (ECLIS)
(Parkin et al., 1993), but the levels of radiation released
suggest that changes should be expected from 5 years after
the accident.
In conclusion, we suggest that further research should be
devoted to determining the exact causes of this increase in
NHL incidence which is, in our series, clearly independent of
the HIV epidemic. It is, however, likely that more and more
HIV-related cases will be registered in the near future. When
possible these should be classified separately as their manage-
ment is very different.
The authors would like to thank their pathologists Drs Michiels.
Dusserre. Bastien and Petrella. and their students Misses Chatelain
and Verret for their active participation.
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